Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
about
Through the looking glass, mechanistic insights from enantiomeric human defensinsAntiviral mechanisms of human defensinsMechanisms and modifications of naturally occurring host defense peptides for anti-HIV microbicide developmentOviduct-specific expression of human neutrophil defensin 4 in lentivirally generated transgenic chickensA novel small-molecule inhibitor of HIV-1 entryAcyl-substituted dermaseptin S4 derivatives with improved bactericidal properties, including on oral microfloraCyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms.Perspectives for clinical use of engineered human host defense antimicrobial peptidesImmunostimulation in the era of the metagenome.Early divergence in neutrophil apoptosis between pathogenic and nonpathogenic simian immunodeficiency virus infections of nonhuman primates.Human beta-defensins suppress human immunodeficiency virus infection: potential role in mucosal protection.Rhesus macaque θ-defensin isoforms: expression, antimicrobial activities, and demonstration of a prominent role in neutrophil granule microbicidal activities.Antimicrobial functionalized genetically engineered spider silk.The CD8-derived chemokine XCL1/lymphotactin is a conformation-dependent, broad-spectrum inhibitor of HIV-1.Human defensins 5 and 6 enhance HIV-1 infectivity through promoting HIV attachment.Multifaceted mechanisms of HIV-1 entry inhibition by human α-defensinNatural antimicrobial peptides as promising anti-HIV candidates.Comparative transcriptome analysis of peripheral blood mononuclear cells in hepatitis B-related acute-on-chronic liver failure.Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract.Human antimicrobial proteins effectors of innate immunity.Cationic host defence peptides: potential as antiviral therapeuticsNeutrophil apoptosis during viral infections.Defensins in viral infections.α-Defensins in human innate immunity.Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.The Role of Defensins in HIV Pathogenesis.Human Antimicrobial Peptides in Bodily Fluids: Current Knowledge and Therapeutic Perspectives in the Postantibiotic Era.The vaginal microbiota, host defence and reproductive physiology.Physicochemical properties that enhance discriminative antibacterial activity of short dermaseptin derivatives.Increased neutrophil apoptosis in chronically SIV-infected macaquesHuman Cytomegalovirus Delays Neutrophil Apoptosis and Stimulates the Release of a Prosurvival Secretome.Human alpha-defensins inhibit BK virus infection by aggregating virions and blocking binding to host cells.Towards the Application of Human Defensins as Antivirals.The Dual Role of Neutrophils in HIV Infection.
P2860
Q24652382-216ED01E-86B2-4669-83E4-C7C8DDCDCB2FQ27023010-89A529D0-9FDC-452A-9596-2281302AB279Q28257799-1A12B30F-7413-47F2-A016-A3BA20E51F47Q28547573-24307952-F581-4D89-B866-D3A23260C56DQ28606625-0DC04E47-E6C6-400F-8AA2-E15574F5D2E4Q33260522-BC836C1D-5F15-4B8A-B7DF-F686A92059A9Q33543787-527FBCAC-D253-4ABD-83F4-4856093036CBQ33700825-6D4A4FC2-3952-4103-8017-7F04CD983F52Q33827416-B183DDEF-8CDA-4E27-84A8-2A01B30A2826Q34072857-1BAB811B-7390-4001-B921-089856CE5C4BQ34124118-43AD3BBD-CC05-4FF6-91C7-506B0D0932DCQ34510136-225D2324-3AF7-482F-9DC5-D3BA0DB52669Q34851126-80F0D2F2-53A1-48A6-A861-60019785230FQ35079838-29D810F4-73D4-40BF-BFD2-3281728317B8Q35136126-C3F6EBF5-1A5F-4916-81D6-3CF0655863BFQ36217242-B1021072-5460-4997-BC8D-CE538CF47532Q36514316-0D7B8F9A-C2CF-4835-AB35-5DE2BE27293FQ36565150-0FDB2609-3592-47B9-BF50-21BCBEAD56F1Q36640429-32D19F77-BD1B-4DAE-823B-DE65CA7C1A99Q37053332-8C7B070E-13CB-4BCD-8D82-18116D7279A0Q37177085-7442D05C-EDA3-472E-8406-8E559C389858Q37538545-FDCE23C4-72C0-4D3C-A15A-A593B15B30E1Q37726739-5840A773-906F-4E22-B925-B1DA22D9939EQ37968296-47768553-5C9D-4227-8036-52A439A78FBDQ38260862-7FBD73E5-CB2B-4F13-AEB7-D0FD37F3ABE8Q38637503-96E67695-E040-4BF0-972B-75AFFD0332F8Q39091774-E7107B29-7A6E-4BE9-A6A6-A8061E81780DQ40626998-E07F7CBF-8140-4786-B1CC-350F48C7064DQ41826503-AD6C18FF-98E2-44DA-A638-D4C60A52E007Q41858915-6C8FB824-78BE-43F4-8E31-D7627F816961Q41921179-41E74CF3-59E5-4536-8EE2-79DFA6A91C17Q42708917-23FF135F-F63A-4E3F-A9CF-BCC588B25B56Q47557198-80B982F5-C26A-47E2-BA6D-95E1E58F41BDQ54260140-0AAD84D9-A858-4CD9-A3E8-CED641D8FDB9
P2860
Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
@ast
Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
@en
Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
@nl
type
label
Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
@ast
Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
@en
Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
@nl
prefLabel
Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
@ast
Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
@en
Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
@nl
P2093
P2860
P1433
P1476
Human neutrophil alpha-defensin 4 inhibits HIV-1 infection in vitro.
@en
P2093
Anthony Devico
Bryan Ericksen
David Gentles
Fiorenza Cocchi
Jacek Lubkowski
Robert I Lehrer
P2860
P304
P356
10.1016/J.FEBSLET.2004.11.062
P407
P577
2005-01-01T00:00:00Z